Cell surface protein cross-linking, coimmmunoprecipitation, and confocal microscopy identified CRLR/RAMP1-, CRLR/RAMP2-, and calcitonin receptor isotype 2 (CTR2)/RAMP1 heterodimers as CGRP-, AM-, and CGRP/amylin receptors, linked to cAMP production. Along these lines, effects of structural alterations in the N-terminal extracellular domain of the human CRLR on cell surface expression as well as the association with RAMP and CGRP or AM have been investigated.
Cell surface protein cross-linking, coimmmunoprecipitation, and confocal microscopy identified CRLR/RAMP1-, CRLR/RAMP2-, and calcitonin receptor isotype 2 (CTR2)/RAMP1 heterodimers as CGRP-, AM-, and CGRP/amylin receptors, linked to cAMP production. Along these lines, effects of structural alterations in the N-terminal extracellular domain of the human CRLR on cell surface expression as well as the association with RAMP and CGRP or AM have been investigated.
Site-directed mutagenesis identified Asn 60 and Asn 112 as N-glycosylation sites. Nglycosylation was important for cell surface expression of CRLR/RAMP complexes, but not for ligand specificity. Substitution of Asn 117 by Asp, on the other hand, maintained normal CRLR function and N-glycosylation, but Asn 117 to Thr, Ala, Gln, or Pro mutations revealed inactive mutant CRLR/RAMP1 heterodimers at the cell surface.
Substitution of the N-terminal 18 amino acids of the CRLR by the corresponding CTR2 domain did not affect RAMP1-dependent CGRP receptor function, but RAMP2-mediated AM binding was abolished and the EC 50 of AM stimulating cAMP accumulation was raised over 100-fold.
In conclusion, differential interactions of CGRP and AM have been identified in the Nterminal extracellular region (1-118) of the human CRLR.
